Six things to know:
1. Second quarter orthopedic sales were $2.3 billion, up 2.1% year-over-year.
2. Hip sales in the second quarter were $417 million, a 4.9% year-over-year increase. Knee sales rose 8.4% with $394 million.
3. Quarterly spine, sports and other sales were $743 million, and trauma sales were $759 million.
4. The company reported total sales of $22.4 billion, a 4.3% increase year-over-year.
5. Johnson and Johnson’s net earnings in the second quarter were $4.7 billion, down from net earnings of $5.4 billion in the same period last year.
6. Operational sales for Johnson & Johnson MedTech grew 4.4%.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
